Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
PaperCitations, authors & open-access status
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 277 citations, 2019 year and bronze oa status.
277
Citations
2019
Year
bronze
OA Status